Instead of thinking about the next generation of Cardiac Safety, we built it
Cardiac safety concerns remain the number one cause for market drug withdrawal. This single fact demands that regulatory submissions for new drugs demonstrate that the proper cardiac safety assessment is conducted
- With Spaulding Cardiac Solutions, you benefit from an industry-leading team of experts, including a world-renowned Cardiologist, that works closely with you to identify cardiac risk early in the drug development process.
- We proactively advise you, building a robust cardiac safety profile that provides you and the regulators, confidence in your decisions related to your compound.
- Using our proprietary technology platform and processes we execute your studies flawlessly, starting with your single ascending/multiple ascending dose studies, through your pivotal Phase III global program, and if required post-approval surveillance.
So choose Spaulding Clinical's Cardiac Solutions team for your next study and get high quality ECG data, in less time and at a lower cost!